Transdermal diclofenac: Phase I started

Phosphagenics began an open-label, Australian Phase I trial comparing 1% and 2% concentrations of topical diclofenac vs. Voltaren 1% diclofenac gel from Novartis AG (NYSE:NVS; SWX:NOVN, Basel, Switze...